Integrated Quantitative Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.12M Buy
3,387
+2,313
+215% +$2.34M 0.57% 26
2025
Q4
$1.15M Buy
+1,074
New +$1.03M 0.25% 166

Other funds holding LLY

Integrated Quantitative Investments's LLY Position: Q1 2026 in Review

Integrated Quantitative Investments increased its Eli Lilly (LLY) stake by 215% in Q1 2026, buying an estimated $2.34M and bringing the position to 3,387 shares worth $3.12M. The position accounts for 0.57% of the portfolio, ranked #26.

Integrated Quantitative Investments first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Integrated Quantitative Investments held 3,387 shares of Eli Lilly worth $3.12M as of Q1 2026.
  • Integrated Quantitative Investments bought 2,313 Eli Lilly shares in Q1 2026, an estimated $2.34M.
  • Eli Lilly made up 0.57% of Integrated Quantitative Investments's portfolio in Q1 2026, its #26 holding.
  • Integrated Quantitative Investments first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.